DPHARM

September 13-14 | Boston, US

We are pleased to announce that we will be sponsoring and attending DPHARM, a unique event focused on the latest innovations that modernize clinical trials.  

We will also participate as speakers in the session “Innovative Patient-Centric Sources & Solutions” in the track “Making DCT’s a Realistic Option for More Patients”.  

Our speaker
Renee Willmon

Renee Willmon

Senior Director, Evidence and Outcomes
Our delegates
Jennifer Lannon

Jennifer Lannon

Director, Patient Advocacy and Partnerships
Damien Joseph

Damien Joseph

Commercial Produce Associate

Would you like to meet Alira Health at DPHARM in Boston? Contact us to set up a meeting. 

Related news

Publications September 16, 2022
Considerations for Analyzing and Interpreting Data from Biometric Monitoring Technologies in Clinical Trials
The rise of technology in clinical research allows us to capture meaningful aspects of health in clinical study participants.
Biometrics Clinical eCOA
Publications September 7, 2022
The Promise and Reality of Decentralized and Hybrid Clinical Trials in Europe Today
To understand the challenges related to hybrid and decentralized trials and ways to overcome them, we spoke with Dr. Hervé Solatges, Product Management, Evidence, and Innovation (DCT(...)
Clinical Decentralized Clinical Trials Hybrid Clinical Trials
Events September 6, 2022
EADV Congress 2022
We are pleased to share that our team will be attending EADV Congress 2022 in Milan this September. EADV Congress is an outstanding educational and learning experience for dermatologists(...)
Decentralized Clinical Trials Digital Therapeutics Real-World Evidence
News September 5, 2022
Alira Health and Legit.Health Partner to Empower Patients in Dermatology Clinical Research
Alira Health digital health solutions combined with Legit.Health’s AI-driven image assessment tool offer a unique platform for dermatology DCT, RWE and DTx.
Decentralized Clinical Trials Dermatology DTx RWE
Publications September 5, 2022
Taking In-Licensed Biologics to Market: Challenges, Complexities, and Ways to Overcome Them
Taking a biologic through drug development to market is highly complex and filled with challenges. To understand these challenges, their implications and how to overcome them, we spoke(...)
Biologics Clinical Drug Development
Events August 25, 2022
Outsourcing in Clinical Trials Southern California 2022
Join us in San Diego on September 28th and 29th and learn about the unparalleled support and value we can offer at every stage of your corporate and product evolution.
Decentralized Clinical Trials Hybrid Clinical Trials Outsourcing Clinical Trials
News August 17, 2022
Alira Health Joins the IRB Barcelona to Advance the Development of Personalized Cancer Treatments
We are pleased to announce we are joining the Institute for Research in Biomedicine (IRB Barcelona) as part of the CGI-Clinics project.
Patient Centric Real-World Evidence RWE
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.